Angiodynamics (ANGO) Depreciation and Depletion (2014 - 2015)

Angiodynamics (ANGO) posted Depreciation and Depletion of $9.4 million for Q2 2015, up 2250.0% on a QoQ basis from $400000.0 in Q3 2014.

Angiodynamics (ANGO) Depreciation and Depletion (2014 - 2015) Analysis & Trends

Angiodynamics' Depreciation and Depletion history runs 2 years deep, the most recent figure standing at $9.4 million for Q2 2015.

Quarterly Depreciation and Depletion changed N/A year-over-year to $9.4 million in Q2 2015, while the trailing twelve-month figure through May 2015 was $9.8 million (changed N/A YoY) and the FY2026 annual result came in at $10.5 million, down 22.22% from the prior year.
Depreciation and Depletion was $9.4 million for Q2 2015 at Angiodynamics, up from $400000.0 in the prior quarter.
Across five years, Depreciation and Depletion topped out at $9.4 million in Q2 2015 and bottomed at $400000.0 in Q3 2014.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Depreciation and Depletion (Qtr)
1	Alcon	32,734,969.19 Bn	32,734,967.53 Bn	1.53 Bn	-
2	Intuitive Surgical	117.50 Bn	112.41 Bn	1.96 Bn	-
3	Becton Dickinson	42.93 Bn	42.11 Bn	2.15 Bn	-
4	Medline	30.82 Bn	36.66 Bn	1.84 Bn	-
5	Resmed	27.90 Bn	26.23 Bn	890.98 Mn	-
6	West Pharmaceutical Services	26.76 Bn	26.23 Bn	329.20 Mn	45.70 Mn
7	Cooper Companies	15.30 Bn	15.16 Bn	735.40 Mn	47.80 Mn
8	Solventum	13.46 Bn	12.90 Bn	1.10 Bn	38.00 Mn
9	Align Technology	12.02 Bn	10.96 Bn	736.59 Mn	15.60 Mn
10	Angiodynamics	558.11 Mn	504.25 Mn	46.77 Mn	-

Download Data